Sort by

Newest

Oldest

Popular

An evaluation of clinical significance of the TP53 polyadenylation signal-disrupting variant
00:10:51
Clinical impact of in-house molecular testing for underserved cancer patients in southern Alabama
00:13:15
Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics
00:11:29
Ethnic and molecular disparities in prostate adenocarcinoma incidence: Data from 19 cohort studies
00:12:44
Invited Speaker: Interpretable & context-free deconvolution of multiscale transcriptomic lung cancer
00:30:12
Invited Speaker Presentation: Current and Future Integrations of Genomics and AI
00:29:20
Keynote Presentation: The Grand Challenge of Cancer Disparities
00:55:37
Implementation and utility of gene expression profile (GEP)-based classification
00:13:04
Best practices for testing and reporting of FISH studies in multiple myeloma
00:12:00
Contextualizing clinical significance using FDA label supplemented DGI data
00:05:01
Enrichment of Hodgkin and Reed-Sternberg (HRS) cells using size-based microfiltration
00:05:58
CGC 2024 Keynote Presentation-Enabling clinical translation of high-throughput functional assay data
00:55:33
Using ClinVar to Share Germline & Somatic Variant Classifications from Clinical Genomic Testing
00:59:15
Exhibitor Showcase: Thermo Fisher
00:17:25
Exhibitor Showcase: Natera
00:14:07
Exhibitor Showcase: Bionano
00:16:15
Exhibitor Showcase: Guardant
00:27:22
Exhibitor Showcase: Novartis
00:13:32
Exhibitor Showcase: Illumina's Oncology Testing Portfolio
00:30:43
Exhibitor Showcase: QIAGEN
00:14:03
Integrative cytogenetic & molecular studies unmasks Chromosomal Mimicry in hematologic malignancies
00:11:06
Implementing the ClinGen/CGC/VICC Oncogenicity Guidelines in a pediatric variant classification
00:11:55
Utilizing rapid molecular testing to reduce disparities in pediatric cancer in Sub-Saharan Africa
00:14:16
Frequency and etiology of cytogenetically cryptic oncogenic fusions in pediatric AML
00:13:46
Prognostic significance of copy number gain of MYC detected by FISH analysis
00:12:07
Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients
00:10:57
Comparative analysis of RNA expression identifies druggable targets in pediatric solid tumors
00:11:19
Investigation of pathogenic and truncated variants of RUNX1 and DDX41 in All of Us
00:11:29
ClinGen Cancer Variant Interpretation (CVI) Committee
00:11:40
Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumors
00:10:46